COVID-19 Drug Pipeline Landscape Report 2024: Comprehensive Insights on 400+ Companies and 400+ Pipeline Drugs
16 avr. 2024 05h02 HE
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "COVID-19 - Pipeline Insight, 2024,"...
CDK9 inhibitor Drug Pipeline Research Report 2024
12 avr. 2024 07h29 HE
|
Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "CDK9 inhibitor - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering."Cyclin-Dependent Kinase 9 (CDK9)...
Antibody Therapeutics (Monoclonal, Polyclonal, Antibody Fragment, Bispecific) Market Research 2023: Advancements in Antibody Engineering and Growing Focus on Collaborations for Drug Discovery
04 avr. 2024 04h12 HE
|
Research and Markets
Dublin, April 04, 2024 (GLOBE NEWSWIRE) -- The "Global Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune &...
COSENTYX (Secukinumab) Market Analysis and Outlook 2019-2032: Mechanism, Dosage, Research, Sales, Regulatory Milestones, Patents, SWOT Analysis
02 avr. 2024 11h47 HE
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "COSENTYX Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Monoclonal Antibodies in Veterinary Health: Global and Regional Market Analysis by Animal Type, Application, End User, and Country - Forecast to 2033
18 mars 2024 05h49 HE
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibodies in Veterinary Health Market: Focus on Animal Type, Application, and End User, Regional Analysis, and Competitive...
Global Therapeutic Antibody Market Research, 2019-2023 and 2024-2029
27 févr. 2024 10h04 HE
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Global Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human,...
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
21 févr. 2024 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla. and NES-ZIONA, Israel, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company specializing in advanced...
Downstream Processing Market Report 2024: Global Trends and Competitive Analysis to 2030 Featuring Thermo Fisher Scientific, GE Healthcare, Sartorius, Merck Millipore, Danaher, and 3M Among Others
21 févr. 2024 06h37 HE
|
Research and Markets
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Downstream Processing Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The...
Global IL-17 Biologics Research Report 2023-2030: A $4.37 Billion Market in 2022 - Advancements in Monoclonal Antibody Engineering Fuel Development of Targeted IL-17 Biologics
20 févr. 2024 10h57 HE
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global IL-17 Biologics Market (2023 Edition): Analysis By Indication, By Drug (Secukinumab, Ixekizumab, Bimekizumab, Brodalumab), By Region, By...
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
13 févr. 2024 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences®...